Abstract
Liver transplantation for pediatric patients has made significant progress since its introduction over 25 years ago. Newer preservation solutions permit elective timing of the procedure and a clearer understanding of the natural history of the underlying liver disease has helped to define those patients most in need of a transplant earlier in the course of their illness. In particular, advances in immunosuppression and in our understanding of immune tolerance will further enhance successful liver engraftment and minimize the risk of infectious illness following transplantation. Gene transfer therapy and "cell" grafts may diminish the need for liver transplantation in selected individuals as advances in molecular biology continue.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
